Dr. Kelley adds two decades of highly relevant drug development and regulatory strategy experience spanning oncology, rare ...
DALLAS--(BUSINESS WIRE)--Starlight Therapeutics— a Lantern Pharma (Nasdaq: LTRN) subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers ...
HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments ...
Cold Spring Harbor Laboratory postdoc Stan Kerstjens and colleagues have devised a new theory for how the brain organizes ...
News-Medical.Net on MSN
Scientists put forward a new theory of brain development
Your brain begins as a single cell. When all is said and done, it will house an incredibly complex and powerful network of some 170 billion cells. How does it organize itself along the way? Cold ...
Accomplished physician-scientist brings more than 30 years of industry leadership experience and CNS drug development expertise. SEATTLE, April 29, 2025 /PRNewswire/ -- Transneural Therapeutics, Inc. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results